4.4 Article

Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure in US veterans

期刊

NEUROTOXICOLOGY
卷 31, 期 5, 页码 493-501

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.neuro.2010.05.006

关键词

Cognitive functioning; Magnetic resonance imaging; Morphometric analysis; Brain; Central nervous system; Chemical warfare agents; Sarin; Cyclosarin; Gulf War veterans

资金

  1. Department of Defense [DAMD17-01-1-0764]
  2. Department of Veteran's Affairs
  3. National Institutes of Health National Center of Research Resources [P41 RR023953]

向作者/读者索取更多资源

Background: Potentially more than 100,000 US troops may have been exposed to the organophosphate chemical warfare agents sarin (GB) and cyclosarin (GF) when a munitions dump at Khamisiyah, Iraq was destroyed during the Gulf War (GW) in 1991. Although little is known about the long-term neurobehavioral or neurophysiological effects of low-dose exposure to GB/GF in humans, recent studies of GW veterans from the Devens Cohort suggest decrements in certain cognitive domains and atrophy in brain white matter occur individuals with higher estimated levels of presumed GB/GF exposure. The goal of the current study is to determine the generalizability of these findings in another cohort of GW veterans with suspected GB/GF exposure. Methods: Neurobehavioral and imaging data collected in a study on Gulf War Illness between 2002 and 2007 were used in this study. We focused on the data of 40 GW-deployed veterans categorized as having been exposed to GB/GF at Khamisiyah, Iraq and 40 matched controls. Magnetic resonance images (MRI) of the brain were analyzed using automated and semi-automated image processing techniques that produced volumetric measurements of gray matter (GM), white matter (WM), cerebrospinal fluid (CSF) and hippocampus. Results: GW veterans with suspected GB/GF exposure had reduced total GM and hippocampal volumes compared to their unexposed peers (p <= 0.01). Although there were no group differences in measures of cognitive function or total WM volume, there were significant, positive correlations between total WM volume and measures of executive function and visuospatial abilities in veterans with suspected GB/GF exposure. Conclusions: These findings suggest that low-level exposure to GB/GF can have deleterious effects on brain structure and brain function more than decade later. (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Substance Abuse

Cerebellar Morphometry and Cognition in the Context of Chronic Alcohol Consumption and Cigarette Smoking

Valerie A. Cardenas, Christina M. Hough, Timothy C. Durazzo, Dieter J. Meyerhoff

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

The gray matter structural connectome and its relationship to alcohol relapse: Reconnecting for recovery

Susanne G. Mueller, Dieter J. Meyerhoff

Summary: Alcohol use disorders (AUD) are associated with gray matter (GM) atrophy, particularly in the frontal lobes, which can impact GM loss in other regions and potentially influence drinking behavior and relapse. Studies show that GM connectivity plays a crucial role in understanding the patterns of GM loss in interconnected regions.

ADDICTION BIOLOGY (2021)

Article Substance Abuse

Medical Conditions Linked to Atherosclerosis Are Associated With Magnified Cortical Thinning in Individuals With Alcohol Use Disorders

Timothy C. Durazzo, Linh-Chi Nguyen, Dieter J. Meyerhoff

ALCOHOL AND ALCOHOLISM (2020)

Article Biochemistry & Molecular Biology

GABA concentrations in the anterior cingulate and dorsolateral prefrontal cortices: Associations with chronic cigarette smoking, neurocognition, and decision making

Timothy C. Durazzo, Dieter J. Meyerhoff

Summary: Chronic cigarette smoking is associated with regional metabolite abnormalities in the human brain, particularly affecting GABA levels in different cortical regions. Smokers had lower GABA levels in the right DLPFC compared to nonsmokers, and higher ACC GABA levels were correlated with better decision-making abilities and auditory-verbal learning in smokers. Longitudinal studies with more female participants are needed to determine if these metabolite abnormalities persist or normalize with smoking cessation.

ADDICTION BIOLOGY (2021)

Article Substance Abuse

Not All Is Lost for Relapsers: Relapsers With Low WHO Risk Drinking Levels and Complete Abstainers Have Comparable Regional Gray Matter Volumes

Dieter J. Meyerhoff, Timothy C. Durazzo

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Article Psychiatry

Does an Over-Connected Visual Cortex Undermine Efforts to Stay Sober After Treatment for Alcohol Use Disorder?

Angela M. Muller, Dieter J. Meyerhoff

FRONTIERS IN PSYCHIATRY (2020)

Article Neurosciences

Maladaptive brain organization at 1 month into abstinence as an indicator for future relapse in patients with alcohol use disorder

Angela M. Muller, Dieter J. Meyerhoff

Summary: Abstinence and relapse are lifelong challenges for patients with AUD. The study revealed that successful recovery from AUD is not linked to regaining the brain organization found in non-drinking controls, but to a new brain configuration distinct from healthy controls. Resting-state fMRI offers valuable insights into neuroplastic adaptations associated with AUD treatment outcomes.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Article Neuroimaging

Age-dependent brain morphometry in Major Depressive disorder

Alison Myoraku, Adam Lang, Charles T. Taylor, R. Scott Mackin, Dieter J. Meyerhoff, Susanne Mueller, Irina A. Strigo, Duygu Tosun

Summary: The study found that differences in brain morphology between MDD patients and healthy controls are dependent on age and brain region, with significant age-by-group interactions in the lateral orbital frontal gyrus and insular subregions, making these regions potential targets for future longitudinal studies of MDD.

NEUROIMAGE-CLINICAL (2022)

Article Psychiatry

Substance-Specific and Shared Gray Matter Signatures in Alcohol, Opioid, and Polysubstance Use Disorder

Angela M. Muller, David L. Pennington, Dieter J. Meyerhoff

Summary: This study found that substance use disorder patients exhibit gray matter loss mainly in the frontal cortex, and the patterns of brain alterations may differ across different types of substance use disorders. These alterations are also associated with functional networks in the brain.

FRONTIERS IN PSYCHIATRY (2022)

Review Biochemistry & Molecular Biology

Brain metabolite alterations related to alcohol use: a meta-analysis of proton magnetic resonance spectroscopy studies

Anna E. Kirkland, Brittney D. Browning, ReJoyce Green, Lorenzo Leggio, Dieter J. Meyerhoff, Lindsay M. Squeglia

Summary: Alcohol misuse and alcohol use disorder have neurobiological consequences as shown by the meta-analysis of proton magnetic resonance spectroscopy studies. These studies reveal alterations in brain metabolite levels, indicating decreased neuronal and axonal viability as well as membrane alterations related to alcohol misuse. The differences in creatine-containing metabolite levels were also noted. This study provides valuable information for further investigation of treatments targeting the observed disturbances.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial

Anna E. E. Kirkland, Brittney D. D. Browning, ReJoyce Green, Helen Liu, Anna M. M. Maralit, Pamela L. L. Ferguson, Dieter J. J. Meyerhoff, James J. J. Prisciandaro, Robert Miranda Jr, Kathleen T. T. Brady, Rachel L. L. Tomko, Kevin M. M. Gray, Lindsay M. M. Squeglia

Summary: Current treatments for adolescent alcohol use disorder (AUD) are limited in their efficacy, so investigating pharmacotherapies as adjunctive treatments is crucial. N-acetylcysteine is a promising candidate due to its tolerability and ability to modulate neurotransmitter systems. This preliminary investigation found no significant differences in brain metabolite levels or alcohol use between N-acetylcysteine and placebo, possibly due to the young age and non-treatment seeking status of the participants.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Substance Abuse

Non-abstinent recovery in alcohol use disorder is associated with greater regional cortical volumes than heavy drinking

A. C. May, D. J. Meyerhoff, T. C. Durazzo

Summary: This study investigated differences in brain structures associated with varying levels of alcohol consumption among individuals with alcohol use disorder (AUD) after treatment. The findings suggest that individuals who consume low-risk levels of alcohol post-treatment have brain volumes more similar to abstainers, indicating that harm reduction may be a beneficial and attainable goal for some individuals seeking treatment for AUD.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Neuroimaging

Frontocerebellar gray matter plasticity in alcohol use disorder linked to abstinence

Angela M. Muller, Dieter J. Meyerhoff

Summary: The study found that alcohol use disorder is associated with brain-wide gray matter reduction, with particular impact on the frontocerebellar circuit. There were significant differences in gray matter volume in the frontocerebellar circuit between abstainers and future relapsers, with abstainers showing increased gray matter with abstinence. Additionally, both AUD groups showed global atrophy relative to controls at follow-up, with different recovery patterns observed.

NEUROIMAGE-CLINICAL (2021)

Meeting Abstract Substance Abuse

WHO SAYS STAYING ABSTINENT IS EASY? SUSTANTIAL RE-CONFIGURATION OF THE INTRINSIC WHOLE-BRAIN-NETWORK ARCHITECTURE IN ABSTAINERS

A. M. Muller, D. J. Meyerhoff

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Meeting Abstract Substance Abuse

AN OVER-CONNECTED VISUAL CORTEX MAY UNDERMINE INDIVIDUAL EFFORTS TO STAY ABSTINENT AFTER TREATMENT FOR ALCOHOL USE DISORDER

A. M. Muller, D. J. Meyerhoff

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

暂无数据